Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04181788
Brief Title: Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

First Submitted : November 14, 2019
First Submitted that Met QC Criteria : November 27, 2019
First Posted : November 29, 2019

Last Update Submitted that Met QC Criteria : June 8, 2021
Last Update Posted : June 11, 2021